Clinical Trial Update: A Repeat Dose Study to Investigate the Interaction of GSK2190915 on the Pharmacokinetics of Rosuvastatin [Phase 1]

View source ↗

Summary

This Phase 1 repeat-dose study assessed how GSK2190915 affects the pharmacokinetics of rosuvastatin, to evaluate potential drug–drug interactions in individuals…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• GSK2190915
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 1 | Status: COMPLETED